Biology Reference
In-Depth Information
Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product
of human papillomavirus type 16. Nature 380:79-82
Ko MA, Rosario CO, Hudson JW, Kulkarni S, Pollett A, Dennis JW, Swallow CJ (2005) Plk4
haploinsufficiency causes mitotic infidelity and carcinogenesis. Nat Genet 37:883-888
Korzeniewski N, Zheng L, Cuevas R, Parry J, Chatterjee P, Anderton B, Duensing A, Munger K,
Duensing S (2009) Cullin 1 functions as a centrosomal suppressor of centriole multiplication
by regulating polo-like kinase 4 protein levels. Cancer Res 69:6668-6675
Korzeniewski N, Treat B, Duensing S (2011) The HPV-16 E7 oncoprotein induces centriole
multiplication through deregulation of Polo-like kinase 4 expression. Mol Cancer 10:61
Lee SS, Glaunsinger B, Mantovani F, Banks L, Javier RT (2000) Multi-PDZ domain protein
MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18
E6 oncoproteins. J Virol 74:9680-9693
Li J, Tan M, Li L, Pamarthy D, Lawrence TS, Sun Y (2005) SAK, a new polo-like kinase, is
transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing. Neoplasia
7:312-323
Liu X, Dakic A, Zhang Y, Dai Y, Chen R, Schlegel R (2009) HPV E6 protein interacts physically
and functionally with the cellular telomerase complex. Proc Natl Acad Sci U S A 106:18780-
18785
Loncarek J, Hergert P, Magidson V, Khodjakov A (2008) Control of daughter centriole formation
by the pericentriolar material. Nat Cell Biol 10:322-328
Longworth MS, Laimins LA (2004a) Pathogenesis of human papillomaviruses in differentiating
epithelia. Microbiol Mol Biol Rev 68:362-372
Longworth MS, Laimins LA (2004b) The binding of histone deacetylases and the integrity of
zinc
finger-like
motifs
of
the
E7
protein
are
essential
for
the
life
cycle
of
human
papillomavirus type 31. J Virol 78:3533-3541
Lyons TE, Salih M, Tuana BS (2006) Activating E2Fs mediate transcriptional regulation of
human E2F6 repressor. Am J Physiol Cell Physiol 290:C189-C199
Massimi P, Shai A, Lambert P, Banks L (2008) HPV E6 degradation of p53 and PDZ containing
substrates in an E6AP null background. Oncogene 27:1800-1804
Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY (1994) D-type cyclin-
dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076
McLaughlin-Drubin ME, Munger K (2009a) Oncogenic activities of human papillomaviruses.
Virus Res 143:195-208
McLaughlin-Drubin
ME,
Munger
K
(2009b)
The
human
papillomavirus
E7
oncoprotein.
Virology 384:335-344
McLaughlin-Drubin ME, Huh KW, Munger K (2008) Human papillomavirus type 16 E7
oncoprotein associates with E2F6. J Virol 82:8695-8705
McLaughlin-Drubin ME, Crum CP, Munger K (2011) Human papillomavirus E7 oncoprotein
induces
KDM6A
and
KDM6B
histone
demethylase
expression
and
causes
epigenetic
reprogramming. Proc Natl Acad Sci U S A 108:2130-2135
Mikhailov A, Cole RW, Rieder CL (2002) DNA damage during mitosis in human cells delays the
metaphase/anaphase transition via the spindle-assembly checkpoint. Curr Biol 12:1797-1806
Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R (1989) The E6 and E7 genes of the
human papillomavirus type 16 together are necessary and sufficient for transformation of
primary human keratinocytes. J Virol 63:4417-4421
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ
(2003) Epidemiologic classification of human papillomavirus types associated with cervical
cancer. N Engl J Med 348:518-527
Nakayama KI, Nakayama K (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat Rev
Cancer 6:369-381
Nguyen CL, Munger K (2008) Direct association of the HPV16 E7 oncoprotein with cyclin A/
CDK2 and cyclin E/CDK2 complexes. Virology 380:21-25
